AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 171 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,238,000 | +0.2% | 67,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,235,000 | -29.7% | 67,100 | -13.9% | 0.00% | -20.0% |
| Q1 2017 | $1,757,000 | +536.6% | 77,900 | +751.4% | 0.01% | +400.0% |
| Q4 2015 | $276,000 | -20.2% | 9,150 | +5.2% | 0.00% | -50.0% |
| Q3 2015 | $346,000 | – | 8,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
| Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
| Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
| FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
| EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
| CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
| Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
| Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
| Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |